829 A potent STING agonist in combination with a novel anti-PD-L1/PD-L2 antibody leads to significant tumor responses in checkpoint-refractory cancers
| Autor: | Michael Curran, James Barlow, Manuela Iezzi, Laura Conti, Elisabetta Bolli, Federica Cavallo, Ahmad Salameh, Paul Blezinger, Christine Gagliardi, Federica Pericle, Chiara Cossu |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023) |
| Druh dokumentu: | article |
| ISSN: | 2051-1426 |
| DOI: | 10.1136/jitc-2023-SITC2023.0829 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|